A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

The baseball field at North Reading High School has been getting a lot of use this season. They've made it to the playoffs ...

A Chicago TV news anchor’s hero firefighter husband has died after years of battling stage 4 brain cancer. ABC 7 Chicago ...

David Izekor was just 18 and in his first year at the University of Leeds when his life took an unexpected turn. One night in ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

Jones' "Today" cohosts shared the news on May 23, five months after the mother of three took a leave of absence from the show ...

A nurses’ union isn’t satisfied with a Mass General Brigham investigation that found the brain tumor cluster at ...

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

This grant has been made possible through tremendous grassroots initiatives and In-memory contributions from across Canada ...